Page last updated: 2024-09-03

7-methoxytacrine and memoquin

7-methoxytacrine has been researched along with memoquin in 1 studies

Compound Research Comparison

Studies
(7-methoxytacrine)
Trials
(7-methoxytacrine)
Recent Studies (post-2010)
(7-methoxytacrine)
Studies
(memoquin)
Trials
(memoquin)
Recent Studies (post-2010) (memoquin)
5212822012

Protein Interaction Comparison

ProteinTaxonomy7-methoxytacrine (IC50)memoquin (IC50)
AcetylcholinesteraseElectrophorus electricus (electric eel)0.0067
Amyloid-beta precursor proteinHomo sapiens (human)5.93
CholinesteraseHomo sapiens (human)1.1808
AcetylcholinesteraseHomo sapiens (human)0.8485
AcetylcholinesteraseRattus norvegicus (Norway rat)0.0016
Beta-secretase 1Homo sapiens (human)0.8567

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andrisano, V; Bartolini, M; Bergamini, C; Bolognesi, ML; Fato, R; Garcia, GE; Korabecny, J; Kuca, K; Lamba, D; Monti, B; Nepovimova, E; Peña-Altamira, LE; Pesaresi, A; Roberti, M; Samez, S; Uliassi, E1

Other Studies

1 other study(ies) available for 7-methoxytacrine and memoquin

ArticleYear
Multitarget drug design strategy: quinone-tacrine hybrids designed to block amyloid-β aggregation and to exert anticholinesterase and antioxidant effects.
    Journal of medicinal chemistry, 2014, Oct-23, Volume: 57, Issue:20

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Animals; Antioxidants; Blood-Brain Barrier; Chemistry Techniques, Synthetic; Cholinesterase Inhibitors; Crystallography, X-Ray; Drug Design; Drug Evaluation, Preclinical; Hep G2 Cells; Humans; Inhibitory Concentration 50; Models, Molecular; Molecular Targeted Therapy; Neurons; Oxidative Stress; Quinones; Rats, Wistar; Tacrine

2014